Cataloging the Structural Variations in Human GeneticsMay 10, 2007
Past studies of human genetic differences usually have focused on the individual "letters" or bases of a DNA sequence. But the genetic differences between humans amount to more than simple spelling errors. "Structural changes — insertions, duplications, deletions, and inversions of DNA — are extremely common in the human population," says Eichler. "In fact, more bases are involved in structural changes in the genome than are involved in single-base-pair changes."
In some cases, individual genes appear in multiple copies because of duplications of DNA segments. In other cases, segments of DNA appear in some people but not others, which means that the "reference" human genome produced by the Human Genome Project is incomplete. "We're finding new sequence in the human genome that is not in the reference sequence," Eichler says.
These structural changes can influence both disease susceptibility and the normal functioning and appearance of the body. Color-blindness, increased risk of prostate cancer, and susceptibility to some forms of cardiovascular disease result from deletions of particular genes or parts of genes. Extra copies of a gene known as CC3L1 reduce a person's susceptibility to HIV infection and progression to AIDS. Lower than normal quantities of other genes can lead to intestinal or kidney diseases.
Variation in the number of genes or in gene regulation caused by structural rearrangements may also contribute to more common diseases. "The million dollar question is what is the genetic basis of diseases like diabetes, hypertension, and high cholesterol levels?" says Eichler. " We know there is a genetic factor, but what is the role of single base pair changes versus structural changes?"
The project Eichler and his colleagues describe in their paper will help answer this question. Using DNA from 62 people who were studied as part of the International HapMap Project, they are creating bacterial "libraries" of DNA segments for each person. The ends of the segments are then sequenced to uncover evidence of structural variation. Whenever such evidence is found, the entire DNA segment is sequenced to catalog all of the genetic differences between the segment and the reference sequence.
The result, says Eichler, will be a tool that geneticists can use to associate structural variation with particular diseases. "It might be that if I have an extra copy of gene A, my threshold for disease X may be higher or lower." Geneticists will then be able to test, or genotype, large numbers of individuals who have a particular disease to look for structural variants that they have in common. If a given variant is contributing to a disease, it will occur at a higher frequency in people with the disease.
Knowing about structural variation in the human genome will also allow geneticists to analyze single-base-pair changes more effectively, according to Aravinda Chakravarti, a geneticist at The Johns Hopkins University School of Medicine who was not a coauthor of the paper. "We have to look at structural variants from a different perspective, because they are adding or subtracting something from the genome," Chakravarti says. By understanding the patterns of both structural variants and single-base-pair changes in the population, "we'll learn a lot." To use both kinds of information in tandem, Eichler and his colleagues plan to incorporate the structural information they gather into existing databases on single-base-pair changes.
The project, which is being funded by the National Human Genome Research Institute at the National Institutes of Health, is difficult and expensive, Eichler admits. "It's a lot of work, because it's essentially doing 62 additional human genome projects," he says. "Having been involved in the first one, I swore I would never do it again. But in this case we're looking at the coolest parts of the genome."
Howard Hughes Medical Institute
Related Human Genetics Current Events and Human Genetics News Articles
Nationwide project paves way for clinical genetic diagnosis
The first nationwide project to genetically diagnose rare diseases will pave the way for translating advances in genomics into patient care in the NHS.
Single genetic abnormality accelerates, removes the brakes on Ewing sarcoma tumor growth
The genetic abnormality that drives the bone cancer Ewing sarcoma operates through two distinct processes - both activating genes that stimulate tumor growth and suppressing those that should keep cancer from developing.
Study reveals that people may inherit 'gut' bacteria that cause Crohn's disease and ulcerative colitis
A new study by an international team of researchers shows for the first time that people may inherit some of the intestinal bacteria that cause Crohn's disease and ulcerative colitis, collectively know as inflammatory bowel disease (IBD).
Big-data analysis reveals gene sharing in mice
Rice University scientists have detected at least three instances of cross-species mating that likely influenced the evolutionary paths of "old world" mice, two in recent times and one in the distant past.
Study: Novel agent decreases neuropathic pain in patients with type 2 diabetes
Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients.
Current practices in reporting on behavioural genetics can mislead the public
"Media reports about behavioural genetics unintentionally induce unfounded beliefs, therefore going against the educational purpose of scientific reporting," writes the University of Montreal's Alexandre Morin-Chassé, following his study of 1,500 Americans.
Scientists map the human loop-ome, revealing a new form of genetic regulation
The ancient Japanese art of origami is based on the idea that nearly any design - a crane, an insect, a samurai warrior - can be made by taking the same blank sheet of paper and folding it in different ways.
Targeting mitochondrial enzyme may reduce chemotherapy drug's cardiac side effects
Massachusetts General Hospital (MGH) investigators have identified two compounds that appear, in cellular and animal models, to block the cardiac damage caused by the important chemotherapy drug doxorubicin.
Long-term results confirm success of MGH-developed laser treatment for vocal-cord cancer
The first long-term study of a pioneering endoscopic laser treatment for early vocal-cord cancer, developed at Massachusetts General Hospital (MGH) and previously shown to provide optimal voice outcomes, finds that it is as successful as traditional approaches in curing patients' tumors while avoiding the damage to vocal quality caused by radiotherapy or by conventional laser or cold-instrument surgery.
Solid-state proteins maximize the intensity of fluorescent-protein-based lasers
The same research team that developed the first laser based on a living cell has shown that use of fluorescent proteins in a solid form rather than in solution greatly increases the intensity of light produced, an accomplishment that takes advantage of natural protein structures surrounding the light-emitting portions of the protein molecules.
More Human Genetics Current Events and Human Genetics News Articles